
#504 - Bill Taranto, President at Merck Global Health Innovation Fund
Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Bill Taranto, President at Merck Global Health Innovation Fund. What you’ll get out of this episode:Bill Taranto’s Journey: From Johnson & Johnson to leading Merck’s $600M GHI Fund focused on digital health and technology.Four Core Investment Areas: Drug discovery, clinical development, supply chain, and patient access/data.Portfolio Spotlights: Companies like Npower, Unnatural Products, Aerosafe Global, Cure AI, and Prognos are driving impactful innovation.Strategic Value of CVCs: Beyond capital, CVCs offer startups technical expertise, commercial agreements, and long-term support.Navigating Market Challenges: Insights on VC pullback, consolidation trends, and advice for startups on sustainable growth. To learn more about Merck: Website https://www.merck.com/ Linkedin https://www.linkedin.com/company/merck/ Our sponsors for this episode are: Sage Growth Partners https://www.sage-growth.com/ Quantum Health https://www.quantum-health.com/ Show and Host's Socials: Slice of Healthcare LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ Jared S Taylor LinkedIn: https://www.linkedin.com/in/jaredstaylor/ WHAT IS SLICE OF HEALTHCARE? The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.
From "Slice of Healthcare"
Comments
Add comment Feedback